← Back to all trials
Recruiting
NCT05597683
Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy
Conditions: Cytoreductive Surgery, Hyperthermic Intra-peritoneal Chemotherapy, Peritoneal Cancer
Sex: All
Ages: 19 Years – N/A
Phase: NA
Enrollment: 50
Sponsor: Gangnam Severance Hospital
Location: Korea, Republic of
Summary
This study aims to assess whether transmusculr quadratus lomborum block (QL block) can reduce postoperative pain after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (CRS and HIPEC).
Patients will be randomly assigned to either QL block group or control group.
Ultrasound-guided bilateral transmuscular quadratus lomborum block will be performed in QL block group using 0.375% ropivacaine.
Multimodal analgesic regimen including acetaminophen, nonsteroidal antiinflammatory drugs (NSAIDs), and rescue opioids will be used in every patient.
Primary outcome is opioid consumption for 24 hours after surgery.
Secondary outcomes included pain scores, time to first rescue analgesics, quality of recovery score, length of hospital stay.
Eligibility Criteria
Inclusion Criteria:- Adult patients who are scheduled to undergo cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (CRS and HIPEC)Exclusion Criteria:Allergy to local anesthetics or fentanylChronic painDrug abusePatients who are unable to use patient-controlled analgesiaSkin infection at site for quadratus lomborum blockpregnant or breatfeeding womenPatients who are unable to communicate
Source: ClinicalTrials.gov (NCT05597683). StuddyBuddy aggregates publicly available trial information.